<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36485/1561-6274-2021-25-2-18-26</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1939</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Патогенез внелегочного поражения органов при инфицировании коронавирусом SARS-CоV-2 (аналитический обзор)</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenesis of extrapulmonary organ damage in SARS-CоV-2 coronavirus infection (analytical review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5251-145X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Литвинов Александр Сергеевич, канд. мед. наук; ведущий научный специалист; заместитель генерального директора по медицинской части</p><p>450000, г. Уфа, ул. Карла Маркса, д. 48/2</p><p>Тел.: +7(347)246-38-16</p><p> г. Лондон</p></bio><bio xml:lang="en"><p>Alexander S. Litvinov, MD, PhD; Leading Scientifi c Specialist, researcher; Deputy Medical Director</p><p>450000, Russia, Ufa, st. Karl Marx, 48/2</p><p>(812)346-39-26</p><p>London, United Kingdom</p><p> </p></bio><email xlink:type="simple">dirge@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2705-1038</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Savin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савин Альберт Владимирович, врач-нефролог, ведущий специалист</p><p>344022, Россия, г. Ростов-на-Дону, ул. Красноармейская, д. 170</p></bio><bio xml:lang="en"><p>Аlbert V. Savin, nephrologist; Leading Scientifi c Specialist, researcher</p><p>344022, Russia, Rostov-on-Don, 170 Krasnoarmeyskaya st.</p><p> </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5963-6634</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кухтина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kukhtina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кухтина Алина Алексеевна, врач-ординатор</p><p>127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1</p><p>Тел.: 8(903)624-77-28</p></bio><bio xml:lang="en"><p>Alina A. Kukhtina, resident</p><p>127473, Russia, Moscow, 20/1 Delegatskaya st.</p><p>8(903)624-77-28</p></bio><email xlink:type="simple">dr.alina.a@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ситовская</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sitovskaya</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ситовская Дарья Александровна, научно-исследовательская лаборатории патоморфологии нервной системы, научн. сотр.</p><p>191014, Россия, Санкт-Петербург, ул. Маяковского, д. 12</p></bio><bio xml:lang="en"><p>Daria A. Sitovskaya, researcher; Leading Scientific Specialist</p><p>191014, Russia, St. Petersburg, 12 Mayakovskogo st.</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Общество с ограниченной ответственностью «Медицинский центр “Агидель”»; Партнерство с ограниченной ответственностью «Metaco LLP»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Limited liability Company "Agidel Medical center";Limited liability Partnership "Metaco LLP"</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Общество с ограниченной ответственностью «ЮгЭкоСервис»; Ограниченное партнерство «Медицинская клиника “Гармония”»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>YugEkoService Limited liability Company; Limited Partnership "Harmony Medical Clinic"</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Московский государственный медико-стоматологический университет им. А.И. Евдокимова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow state medical and dental University named after A. I. Evdokimov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Российский научно-исследовательский нейрохирургический институт им. проф. А. Л. Поленова (филиал Национального медицинского исследовательского центра им. В.А. Алмазова); Городская Мариинская больница; Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Research Neurosurgical Institute professor A.L. Polenov (a branch of the National Medical Research Center named V.A. Almazov); City Mariinsky Hospital; St. Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>02</month><year>2021</year></pub-date><volume>25</volume><issue>2</issue><fpage>18</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Литвинов А.С., Савин А.В., Кухтина А.А., Ситовская Д.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Литвинов А.С., Савин А.В., Кухтина А.А., Ситовская Д.А.</copyright-holder><copyright-holder xml:lang="en">Litvinov A.S., Savin A.V., Kukhtina A.A., Sitovskaya D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1939">https://journal.nephrolog.ru/jour/article/view/1939</self-uri><abstract><p>За последние два десятилетия коронавирусная инфекция вызвала две масштабные пандемии: атипичную пневмонию (SARS) в 2002 г. и острый респираторный синдром (MERS) на Ближнем Востоке в 2012 г. В декабре 2019 года новый коронавирус (КВ) SARS-CoV-2 вызвал вспышку пневмонии в г. Ухань, Китай. Специалисты Всемирной организации здравоохранения (ВОЗ) подтвердили риск данного заболевания для общественного здоровья всей планеты. SARS-CoV-2 был выделен из эпителиальных клеток дыхательных путей человека. Было обнаружено, что генотип КВ SARS-CoV-2 ближе к bat-SL-CoVZC45 и bat-SL-CoVZXC21, а спайковый гликопротеин (СБ) вируса, определяющий возможность связывания с клеточным рецептором, подобен коронавирусу SARS-CoV, ответственному за вспышку тяжелого острого респираторного синдрома (ТОРС/SARS) в 2002 г.]. Ангиотензин-превращающий фермент 2 (АПФ2) является эндогенным спайковым белком (спайковый гликопротеин с S-доменом) SARS-CoV-2, который в составе комплекса АПФ2+SARS-CoV-2 связывается с рецептором АПФ2, находящимся на мембране клетки-мишени. В статье рассматриваются механизмы заражения SARS-CoV-2, межклеточные взаимодействия и пути передачи инфекции. Подробно освещены вопросы эпидемиологии COVID-19 и перспективы вовлечения других органов и систем, кроме дыхательной, в поддержание вирусной нагрузки. Выявлены проблемы иммунной защиты организма человека при инфицировании SARS-CoV-2. Проведены клинические параллели с вирусами-предшественниками, а именно SARS-CoV-1 и MERS-CoV. Выделены факторы риска инфицированности SARS-CoV-2, позволяющие прогнозировать характер течения и вероятные исходы COVID-19.</p></abstract><trans-abstract xml:lang="en"><p>Over the past two decades, coronavirus infection has caused two major pandemics: SARS in 2002 and acute respiratory syndrome (MERS) in the Middle East in 2012. In December 2019, the novel coronavirus (CV) SARS-CoV-2 caused an outbreak of pneumonia in Wuhan, China. Experts from the World Health Organization (WHO) have confirmed the risk of this disease for the public health of the entire planet. SARS-CoV-2 was isolated from epithelial cells of the human respiratory tract. It was found that the genotype KB SARS-CoV-2 is closer to bat-SL-CoVZC45 and bat-SL-CoVZXC21, and the spike glycoprotein (SB) of the virus, which determines the ability to bind to the cellular receptor, is similar to the SARS-CoV coronavirus, which is responsible for the outbreak of severe acute respiratory syndrome (SARS / SARS) in 2002]. Angiotensin-converting enzyme 2 (ACE2) is an endogenous spike protein (spike glycoprotein with the S-domain) SARS-CoV-2, which, as part of the ACE2 + SARS-CoV-2 complex, binds to the ACE2 receptor located on the target cell membrane. The article discusses the mechanisms of infection with SARS-CoV-2, cell-cell interactions, and transmission routes. The issues of the epidemiology of COVID-19 and the prospects for the involvement of organs and systems other than the respiratory one in maintaining the viral load are covered in detail. The problems of the immune defense of the human body during infection with SARS-CoV-2 have been identified. Clinical parallels with progenitor viruses, namely SARS-CoV-1 and MERS-CoV, have been drawn. Highlighted risk factors for SARSCoV-2 infection, which make it possible to predict the nature of the course and probable outcomes of COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>ангиотензин-превращающий фермент 2</kwd><kwd>ангиотензин 1-7</kwd><kwd>трансмембранная протеаза</kwd><kwd>серин 2</kwd><kwd>клетка-мишень</kwd><kwd>альвеолоцит 2-го типа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>angiotensin-converting enzyme 2</kwd><kwd>angiotensin 1-7</kwd><kwd>transmembrane protease</kwd><kwd>serine 2</kwd><kwd>target cell</kwd><kwd>type 2 alveolocyte</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523-534. doi: 10.1038/nrmicro.2016.81</mixed-citation><mixed-citation xml:lang="en">De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523-534. doi: 10.1038/nrmicro.2016.81</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 2020. doi: 10.1002/jmv.25681</mixed-citation><mixed-citation xml:lang="en">Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 2020. doi: 10.1002/jmv.25681</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu N. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med. Available at: www.nejm.org/doi/full/10.1056/NEJMoa2001017</mixed-citation><mixed-citation xml:lang="en">Zhu N. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med. Available at: www.nejm.org/doi/full/10.1056/NEJMoa2001017</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lu R. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. doi: 10.1016/S0140-6736(20)30251-8</mixed-citation><mixed-citation xml:lang="en">Lu R. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. doi: 10.1016/S0140-6736(20)30251-8</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ji W, Wang W, Zhao X et al. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol 2020;92:433-440. doi: 10.1002/jmv.25682</mixed-citation><mixed-citation xml:lang="en">Ji W, Wang W, Zhao X et al. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol 2020;92:433-440. doi: 10.1002/jmv.25682</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rice GI, Thomas DA, Grant PJ et al. Evaluation of angiotensin converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004;383:45-51</mixed-citation><mixed-citation xml:lang="en">Rice GI, Thomas DA, Grant PJ et al. Evaluation of angiotensin converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004;383:45-51</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. TIPS 2002;23:177-183</mixed-citation><mixed-citation xml:lang="en">Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. TIPS 2002;23:177-183</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell MC. Emerging evidence for a functional angiotesinconverting enzyme 2-angiotensin-(1-7) mas receptor axis; more than regulation of blood pressure? Hypertension 2007;50:596-599</mixed-citation><mixed-citation xml:lang="en">Chappell MC. Emerging evidence for a functional angiotesinconverting enzyme 2-angiotensin-(1-7) mas receptor axis; more than regulation of blood pressure? Hypertension 2007;50:596-599</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. In: Suzuki H, Saruta T, editors. Kidney and Blood Pressure Regulation. Basel; Karger: 2004</mixed-citation><mixed-citation xml:lang="en">Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. In: Suzuki H, Saruta T, editors. Kidney and Blood Pressure Regulation. Basel; Karger: 2004</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertensionn1998; 31:362-367</mixed-citation><mixed-citation xml:lang="en">Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertensionn1998; 31:362-367</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Vickers C, Hales P, Kaushik V et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002;277:14838-14843</mixed-citation><mixed-citation xml:lang="en">Vickers C, Hales P, Kaushik V et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002;277:14838-14843</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Oudit GY, Herzenberg AM, Kassiri Z et al. Loss of angiotensinconverting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Patho 2006;168:1808-1820</mixed-citation><mixed-citation xml:lang="en">Oudit GY, Herzenberg AM, Kassiri Z et al. Loss of angiotensinconverting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Patho 2006;168:1808-1820</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ye M, Wysocki J, William J et al. Glomerular localization and expression of angiotension-converting enzyme 2 and angiotensinconverting enzyme: Implications for albuminemia in diabetes. J Am Soc Nephrol 2006;17:3067-3075</mixed-citation><mixed-citation xml:lang="en">Ye M, Wysocki J, William J et al. Glomerular localization and expression of angiotension-converting enzyme 2 and angiotensinconverting enzyme: Implications for albuminemia in diabetes. J Am Soc Nephrol 2006;17:3067-3075</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pendergrass KD, Pirro NT, Westwood BM et al. Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol 2008;295:10-20</mixed-citation><mixed-citation xml:lang="en">Pendergrass KD, Pirro NT, Westwood BM et al. Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol 2008;295:10-20</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Prieto MC, Gonzalez-Villalobos RA, Botros FT et al. Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2011;300:749-755</mixed-citation><mixed-citation xml:lang="en">Prieto MC, Gonzalez-Villalobos RA, Botros FT et al. Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2011;300:749-755</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Allred AJ, Diz DI, Ferrario CM, Chappell MC. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol 2000;279:841-850</mixed-citation><mixed-citation xml:lang="en">Allred AJ, Diz DI, Ferrario CM, Chappell MC. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol 2000;279:841-850</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin-( 1-7) metabolism in the kidney. Nephrol Dial Transplant 2001;16:22-26</mixed-citation><mixed-citation xml:lang="en">Chappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin-( 1-7) metabolism in the kidney. Nephrol Dial Transplant 2001;16:22-26</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell MC, Gomez MN, Pirro NT, Ferrario CM. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensinconverting enzyme inhibition. Hypertension 2000;35:348-352</mixed-citation><mixed-citation xml:lang="en">Chappell MC, Gomez MN, Pirro NT, Ferrario CM. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensinconverting enzyme inhibition. Hypertension 2000;35:348-352</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Velez JC, Ryan KJ, Harbeson CE et al. Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli. Hypertension 2009;53:790-797</mixed-citation><mixed-citation xml:lang="en">Velez JC, Ryan KJ, Harbeson CE et al. Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli. Hypertension 2009;53:790-797</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertensionn1992; 19:692-696</mixed-citation><mixed-citation xml:lang="en">Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertensionn1992; 19:692-696</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sampaio WO, dos Santos RA, Faria-Silva R et al. Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007;49:185-192</mixed-citation><mixed-citation xml:lang="en">Sampaio WO, dos Santos RA, Faria-Silva R et al. Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007;49:185-192</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoEdeficient mice. Circulation 2001;103:448-454</mixed-citation><mixed-citation xml:lang="en">Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoEdeficient mice. Circulation 2001;103:448-454</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibitis angiotensin II stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006;69: 2212-2218</mixed-citation><mixed-citation xml:lang="en">Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibitis angiotensin II stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006;69: 2212-2218</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Iyer SN, Yamada K, Diz DI et al. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin (1-7) during chronic blockade of the renin angiotensin system. J Cardiovasc Pharmacol 2000;36:109-117</mixed-citation><mixed-citation xml:lang="en">Iyer SN, Yamada K, Diz DI et al. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin (1-7) during chronic blockade of the renin angiotensin system. J Cardiovasc Pharmacol 2000;36:109-117</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Giani JF, Munoz MC, Pons RA et al. Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol 2011;300:272-282</mixed-citation><mixed-citation xml:lang="en">Giani JF, Munoz MC, Pons RA et al. Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol 2011;300:272-282</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-696</mixed-citation><mixed-citation xml:lang="en">Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-696</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 2010;298:579-588</mixed-citation><mixed-citation xml:lang="en">Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 2010;298:579-588</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Soler MJ, Wysocki J, Ye M et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin induced diabetic mice. Kid Int 2007;72:614-623</mixed-citation><mixed-citation xml:lang="en">Soler MJ, Wysocki J, Ye M et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin induced diabetic mice. Kid Int 2007;72:614-623</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Tikellis C, Bialkowski K, Pete J et al. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008;57:1018-1025</mixed-citation><mixed-citation xml:lang="en">Tikellis C, Bialkowski K, Pete J et al. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008;57:1018-1025</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wong DW, Oudit GY, Reich H et al. Loss of angiotensinconverting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007;171:438-451</mixed-citation><mixed-citation xml:lang="en">Wong DW, Oudit GY, Reich H et al. Loss of angiotensinconverting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007;171:438-451</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Glowacka I, Bertram S, Muller MA et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011;85:4122-4134</mixed-citation><mixed-citation xml:lang="en">Glowacka I, Bertram S, Muller MA et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011;85:4122-4134</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bertram S, Dijkman R, Habjan M et al. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 2013;87:6150-6160</mixed-citation><mixed-citation xml:lang="en">Bertram S, Dijkman R, Habjan M et al. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 2013;87:6150-6160</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Abe M, Tahara M, Sakai K et al. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol 2013;87:11930-11935</mixed-citation><mixed-citation xml:lang="en">Abe M, Tahara M, Sakai K et al. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol 2013;87:11930-11935</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol 2013;87:12552-12561</mixed-citation><mixed-citation xml:lang="en">Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol 2013;87:12552-12561</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Heurich A, Hofmann-Winkler H, Gierer S et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 2014;88:1293-1307</mixed-citation><mixed-citation xml:lang="en">Heurich A, Hofmann-Winkler H, Gierer S et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 2014;88:1293-1307</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Vaarala MH, Porvari KS, Kellokumpu S et al. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. J Pathol 2001;193:134-140</mixed-citation><mixed-citation xml:lang="en">Vaarala MH, Porvari KS, Kellokumpu S et al. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. J Pathol 2001;193:134-140</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Chen YW, Lee MS, Lucht A et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996</mixed-citation><mixed-citation xml:lang="en">Chen YW, Lee MS, Lucht A et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Donaldson SH, Hirsh A, Li DC et al. Regulation of the epithelial sodium channel by serine proteases in human airways. J Biol Chem 2002;277:8338-8345</mixed-citation><mixed-citation xml:lang="en">Donaldson SH, Hirsh A, Li DC et al. Regulation of the epithelial sodium channel by serine proteases in human airways. J Biol Chem 2002;277:8338-8345</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Chen YW, Lee MS, Lucht A et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996</mixed-citation><mixed-citation xml:lang="en">Chen YW, Lee MS, Lucht A et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson S, Greer B, Hooper J et al. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem J 2005;388:967-972</mixed-citation><mixed-citation xml:lang="en">Wilson S, Greer B, Hooper J et al. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem J 2005;388:967-972</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bottcher-Friebertshauser E, Freuer C, Sielaff F et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 2010;84:5605-5614</mixed-citation><mixed-citation xml:lang="en">Bottcher-Friebertshauser E, Freuer C, Sielaff F et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 2010;84:5605-5614</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Bottcher E, Matrosovich T, Beyerle M et al. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 2006;80:9896-9898</mixed-citation><mixed-citation xml:lang="en">Bottcher E, Matrosovich T, Beyerle M et al. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 2006;80:9896-9898</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Shulla A, Heald-Sargent T, Subramanya G et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol 2011;85:873-882</mixed-citation><mixed-citation xml:lang="en">Shulla A, Heald-Sargent T, Subramanya G et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol 2011;85:873-882</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hamming I, Timens W, Bulthuis ML. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol 2004;203:631-637. Available at: www.onlinelibrary.wiley.com/doi/abs/10.1002/path.1570/</mixed-citation><mixed-citation xml:lang="en">Hamming I, Timens W, Bulthuis ML. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol 2004;203:631-637. Available at: www.onlinelibrary.wiley.com/doi/abs/10.1002/path.1570/</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sims AC, Baric RS, Yount B. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 2005;79:15511-15524. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1316022/</mixed-citation><mixed-citation xml:lang="en">Sims AC, Baric RS, Yount B. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 2005;79:15511-15524. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1316022/</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira Braga FA, Kar G, Berg M. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 2019;25:1153-1163. Available at: https://www.nature.com/articles/s41591-019-0468-5</mixed-citation><mixed-citation xml:lang="en">Vieira Braga FA, Kar G, Berg M. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 2019;25:1153-1163. Available at: https://www.nature.com/articles/s41591-019-0468-5</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y, Mizuno T, Sridharan A. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight 2016;1:134-139</mixed-citation><mixed-citation xml:lang="en">Xu Y, Mizuno T, Sridharan A. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight 2016;1:134-139</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 2020; Feb 17. doi: 10.1016/j.bbrc.2020.02.071</mixed-citation><mixed-citation xml:lang="en">Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 2020; Feb 17. doi: 10.1016/j.bbrc.2020.02.071</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hashimoto T, Perlot T, Rehman A et al. ACE2 links amino acid malnutrition to microbial ecology andf intestinal inflammation. Nature 2012;487(7408):477-481. doi: 10.1038/nature11228</mixed-citation><mixed-citation xml:lang="en">Hashimoto T, Perlot T, Rehman A et al. ACE2 links amino acid malnutrition to microbial ecology andf intestinal inflammation. Nature 2012;487(7408):477-481. doi: 10.1038/nature11228</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect. Dis Clin 2019;33:869-889. Available at: https://www.sciencedirect.com/science/article/pii/S0891552019300571?via%3Dihub//Ho</mixed-citation><mixed-citation xml:lang="en">Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect. Dis Clin 2019;33:869-889. Available at: https://www.sciencedirect.com/science/article/pii/S0891552019300571?via%3Dihub//Ho</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">lshue ML, DeBolt C, Lindquist S. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; Jan 31. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</mixed-citation><mixed-citation xml:lang="en">lshue ML, DeBolt C, Lindquist S. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; Jan 31. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama.2020.1585</mixed-citation><mixed-citation xml:lang="en">Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama.2020.1585</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020. doi: 10.1016/S0140-6736(20)30183-5</mixed-citation><mixed-citation xml:lang="en">Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020. doi: 10.1016/S0140-6736(20)30183-5</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Guan W, Ni Z, Hu Y et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020. doi: 10.1101/2020.02.06.20020974</mixed-citation><mixed-citation xml:lang="en">Guan W, Ni Z, Hu Y et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020. doi: 10.1101/2020.02.06.20020974</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Zhao Z, Wang Y et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. medRxiv 2020. doi: 10.1101/2020.01.26.919985</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Zhao Z, Wang Y et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. medRxiv 2020. doi: 10.1101/2020.01.26.919985</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Xu X. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020. doi: 10.1007/s11427-020-1637-5</mixed-citation><mixed-citation xml:lang="en">Xu X. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020. doi: 10.1007/s11427-020-1637-5</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Zou X. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front Med 2020. Available at: www.journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0</mixed-citation><mixed-citation xml:lang="en">Zou X. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front Med 2020. Available at: www.journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou P. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. doi: 10.1038/s41586-020-2012-7</mixed-citation><mixed-citation xml:lang="en">Zhou P. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. doi: 10.1038/s41586-020-2012-7</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Li W. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-454. doi: 10.1038/nature02145</mixed-citation><mixed-citation xml:lang="en">Li W. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-454. doi: 10.1038/nature02145</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Hofmann H. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 2005;102:7988-7993. doi: 10.1073/pnas.0409465102</mixed-citation><mixed-citation xml:lang="en">Hofmann H. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 2005;102:7988-7993. doi: 10.1073/pnas.0409465102</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint 2020. Available at: www.biorxiv.org/content/10.1101/2020.01.26.919985v1</mixed-citation><mixed-citation xml:lang="en">Zhao Y. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint 2020. Available at: www.biorxiv.org/content/10.1101/2020.01.26.919985v1</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H. The digestive system is a potential route of 2019- nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint 2020. Available at: https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1</mixed-citation><mixed-citation xml:lang="en">Zhang H. The digestive system is a potential route of 2019- nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint 2020. Available at: https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Chai X. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint 2020. Available at: www.biorxiv.org/content/10.1101/2020.02.03.931766v1</mixed-citation><mixed-citation xml:lang="en">Chai X. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint 2020. Available at: www.biorxiv.org/content/10.1101/2020.02.03.931766v1</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417(6891):822-828. doi: 10.1038/nature00786</mixed-citation><mixed-citation xml:lang="en">Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417(6891):822-828. doi: 10.1038/nature00786</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Danilczyk U, Sarao R, Remy C et al. Essential role for collectrin in renal amino acid transport. Nature 2006;444(7122):1088-1091. doi: 10.1038/nature05475</mixed-citation><mixed-citation xml:lang="en">Danilczyk U, Sarao R, Remy C et al. Essential role for collectrin in renal amino acid transport. Nature 2006;444(7122):1088-1091. doi: 10.1038/nature05475</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Gu J, Gong E, Zhang B et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202(3):415-424. doi: 10.1084/jem.20050828</mixed-citation><mixed-citation xml:lang="en">Gu J, Gong E, Zhang B et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202(3):415-424. doi: 10.1084/jem.20050828</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Ding Y, He L, Zhang Q et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004;203:622-630. doi: 10.1002/path.1560</mixed-citation><mixed-citation xml:lang="en">Ding Y, He L, Zhang Q et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004;203:622-630. doi: 10.1002/path.1560</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Hamming I, Timens W, Bulthuis MLC et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631-663. doi: 10.1002/path.1570</mixed-citation><mixed-citation xml:lang="en">Hamming I, Timens W, Bulthuis MLC et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631-663. doi: 10.1002/path.1570</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Ren X. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 2006;87:1691-1695. doi: 10.1099/vir.0.81749-0</mixed-citation><mixed-citation xml:lang="en">Ren X. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 2006;87:1691-1695. doi: 10.1099/vir.0.81749-0</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Xu H, Zhong L, Deng J et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12:8</mixed-citation><mixed-citation xml:lang="en">Xu H, Zhong L, Deng J et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12:8</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Tawfiq JA, Zumla, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12:422-428. doi: 10.1016/j.tmaid.2014.06.007</mixed-citation><mixed-citation xml:lang="en">Al-Tawfiq JA, Zumla, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12:422-428. doi: 10.1016/j.tmaid.2014.06.007</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou P, Yang X.-L, Wang X-G et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;12:23-28. doi: 10.1038/s41586-020-2012-7</mixed-citation><mixed-citation xml:lang="en">Zhou P, Yang X.-L, Wang X-G et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;12:23-28. doi: 10.1038/s41586-020-2012-7</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5</mixed-citation><mixed-citation xml:lang="en">Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Wan Y, Shang J, Graham R et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol 2020;46:35-36. doi: 10.1128/JVI.00127-20</mixed-citation><mixed-citation xml:lang="en">Wan Y, Shang J, Graham R et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol 2020;46:35-36. doi: 10.1128/JVI.00127-20</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Li F. Structure, function, and evolution of coronavirus spike proteins. Ann Rev Virol 2016;3:237-261</mixed-citation><mixed-citation xml:lang="en">Li F. Structure, function, and evolution of coronavirus spike proteins. Ann Rev Virol 2016;3:237-261</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Simmons G, Zmora P, Gierer S et al. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res 2013;100:605-614</mixed-citation><mixed-citation xml:lang="en">Simmons G, Zmora P, Gierer S et al. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res 2013;100:605-614</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuyama S. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 2010;84:12658-12664</mixed-citation><mixed-citation xml:lang="en">Matsuyama S. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 2010;84:12658-12664</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Bertram S. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 2011;85:13363-13372</mixed-citation><mixed-citation xml:lang="en">Bertram S. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 2011;85:13363-13372</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 2009;106:5871-5876</mixed-citation><mixed-citation xml:lang="en">Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 2009;106:5871-5876</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005;309:1864-1868</mixed-citation><mixed-citation xml:lang="en">Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005;309:1864-1868</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res 2015;202:120-134</mixed-citation><mixed-citation xml:lang="en">Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res 2015;202:120-134</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Woodward Davis AS, Roozen HN, Dufort MJ et al. The human tissue-resident CCR5(+) T cell compartment maintains protective and functional properties during inflammation. Sci Transl Med 2019;11(521):871-878. doi: 10.1126/scitranslmed.aaw8718</mixed-citation><mixed-citation xml:lang="en">Woodward Davis AS, Roozen HN, Dufort MJ et al. The human tissue-resident CCR5(+) T cell compartment maintains protective and functional properties during inflammation. Sci Transl Med 2019;11(521):871-878. doi: 10.1126/scitranslmed.aaw8718</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Yao XH, Li TY, He ZC. A pathological report of three COVID-19 cases by minimally invasive autopsies. Nature 2020;24:132-133. doi: 10.3760/cma.j.cn112151-20200312-00193. 32172546</mixed-citation><mixed-citation xml:lang="en">Yao XH, Li TY, He ZC. A pathological report of three COVID-19 cases by minimally invasive autopsies. Nature 2020;24:132-133. doi: 10.3760/cma.j.cn112151-20200312-00193. 32172546</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Diao B, Feng Z, Wang C et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MedRxiv 2020;200: 31-36</mixed-citation><mixed-citation xml:lang="en">Diao B, Feng Z, Wang C et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MedRxiv 2020;200: 31-36</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Xu D, Zhang H, Gong H et al. Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. Preprints 2020. Available at: www.preprints.org/manuscript/202002.0331/v1</mixed-citation><mixed-citation xml:lang="en">Xu D, Zhang H, Gong H et al. Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. Preprints 2020. Available at: www.preprints.org/manuscript/202002.0331/v1</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Haddadi S, Vaseghi-Shanjani M, Yao Y et al. Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells. Front Immunol 2019;10:2075. doi: 10.3389/fimmu.2019.02075</mixed-citation><mixed-citation xml:lang="en">Haddadi S, Vaseghi-Shanjani M, Yao Y et al. Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells. Front Immunol 2019;10:2075. doi: 10.3389/fimmu.2019.02075</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
